{"title":"In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations","authors":"Leandro L. Santos, Nathaniel J. Swofford, Brandon G. Santiago","doi":"10.1002/cpph.79","DOIUrl":null,"url":null,"abstract":"<p>In vitro assessment of topical (dermal) pharmacokinetics is a critical aspect of the drug development process for semi-solid products (e.g., solutions, foams, sprays, creams, gels, lotions, ointments), allowing for informed selection of new chemical entities, optimization of prototype formulations during the nonclinical stage, and determination of bioequivalence of generics. It can also serve as a tool to further understand the impact of different excipients on drug delivery, product quality, and formulation microstructure when used in parallel with other techniques, such as analyses of rheology, viscosity, microscopic characteristics, release rate, particle size, and oil droplet size distribution. The in vitro permeation test (IVPT), also known as in vitro skin penetration/permeation test, typically uses ex vivo human skin in conjunction with diffusion cells, such as Franz (or vertical) or Bronaugh (or flow-through) diffusion cells, and is the technique of choice for dermal pharmacokinetics assessment. Successful execution of the IVPT also involves the development and use of fit-for-purpose bioanalytical methods and procedures. The protocols described herein provide detailed steps for execution of the IVPT utilizing flow-through diffusion cells and for key aspects of the development of a liquid chromatography–tandem mass spectrometry method intended for analysis of the generated samples (epidermis, dermis, and receptor solution). © 2020 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: In vitro permeation test</p><p><b>Support Protocol</b>: Dermatoming of ex vivo human skin</p><p><b>Basic Protocol 2</b>: Bioanalytical methodology in the context of the in vitro permeation test</p>","PeriodicalId":10871,"journal":{"name":"Current Protocols in Pharmacology","volume":"91 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpph.79","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpph.79","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 13
Abstract
In vitro assessment of topical (dermal) pharmacokinetics is a critical aspect of the drug development process for semi-solid products (e.g., solutions, foams, sprays, creams, gels, lotions, ointments), allowing for informed selection of new chemical entities, optimization of prototype formulations during the nonclinical stage, and determination of bioequivalence of generics. It can also serve as a tool to further understand the impact of different excipients on drug delivery, product quality, and formulation microstructure when used in parallel with other techniques, such as analyses of rheology, viscosity, microscopic characteristics, release rate, particle size, and oil droplet size distribution. The in vitro permeation test (IVPT), also known as in vitro skin penetration/permeation test, typically uses ex vivo human skin in conjunction with diffusion cells, such as Franz (or vertical) or Bronaugh (or flow-through) diffusion cells, and is the technique of choice for dermal pharmacokinetics assessment. Successful execution of the IVPT also involves the development and use of fit-for-purpose bioanalytical methods and procedures. The protocols described herein provide detailed steps for execution of the IVPT utilizing flow-through diffusion cells and for key aspects of the development of a liquid chromatography–tandem mass spectrometry method intended for analysis of the generated samples (epidermis, dermis, and receptor solution). © 2020 Wiley Periodicals LLC.
Basic Protocol 1: In vitro permeation test
Support Protocol: Dermatoming of ex vivo human skin
Basic Protocol 2: Bioanalytical methodology in the context of the in vitro permeation test
体外渗透试验(IVPT)用于局部皮肤病制剂的药代动力学评估
局部(皮肤)药代动力学的体外评估是半固体产品(如溶液、泡沫、喷雾剂、面霜、凝胶、乳液、软膏)药物开发过程的一个关键方面,允许对新的化学实体进行知情选择,在非临床阶段优化原型配方,并确定仿制药的生物等效性。它还可以作为一种工具,进一步了解不同辅料对药物传递、产品质量和配方微观结构的影响,当与其他技术并行使用时,如流变学、粘度、微观特性、释放速度、粒度和油滴大小分布的分析。体外渗透试验(IVPT),也称为体外皮肤渗透/渗透试验,通常使用离体人体皮肤与扩散细胞(如Franz(或垂直)或Bronaugh(或流动)扩散细胞)结合使用,是皮肤药代动力学评估的首选技术。IVPT的成功执行还包括开发和使用适合目的的生物分析方法和程序。本文描述的方案提供了使用流式扩散池执行IVPT的详细步骤,以及用于分析生成样品(表皮、真皮和受体溶液)的液相色谱-串联质谱方法开发的关键方面。©2020 Wiley期刊有限公司基本方案1:体外渗透试验支持方案:离体人体皮肤的皮肤形成基本方案2:体外渗透试验背景下的生物分析方法
本文章由计算机程序翻译,如有差异,请以英文原文为准。